Akari Therapeutics
AKTX | NASDAQ
$8.10
-$0.15 (-1.82%)
Nov 2, 2026, 10:33 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -4.81M | -14.46M | -7.19M | -6.36M | -1.9M | -3.71M | -3.77M | -2.9M | -7.56M | -5.57M | -4.14M | -2.87M | -4M | 1M | n/a | -3.45K | -5.68M | -5.18M | -5.79M | -1.45M | -4.35M | -5.84M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | 13K | 1K | 1K | 1K | 1K | 1.03K | 1.03K | 942 | 1.01K | 1.01K | 1.03K | 1.05K | 1.03K |
Stock-Based Compensation | 711K | 305K | 1.19M | n/a | 719K | 1.02M | 1.26M | 248K | 445 | 296K | 304K | 305K | 276K | 265K | n/a | 256.65 | 122.86K | 98.84K | 77.05K | 70.61K | 82.1K | 84.89K |
Other Working Capital | -1.36M | 835.6K | 151K | -577.83K | -416K | 567K | 1.54M | 1.35M | 564 | 1.6M | 193K | 46K | -374K | -563K | n/a | 2.2K | -2.96M | 109.3K | 898.21K | -177.73K | -531.66K | -1.93M |
Other Non-Cash Items | 1.73M | 11.69M | 2.81M | 5.93M | -1.66M | -27K | -1.15M | -189K | 2.66M | -385K | -769K | 70K | -597K | -5.58M | -1.03K | -3.98K | -54.14K | -82.36K | 49.21K | -1.33K | -70.87K | 265.48K |
Deferred Income Tax | n/a | -859K | n/a | -1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -739K | 835.6K | 151K | -577.83K | -416K | 567K | 1.54M | 1.35M | 564 | 1.6M | 193K | 46K | -374K | -563K | n/a | 2.2K | -2.96M | 109.3K | 656.9K | -177.73K | -531.66K | -1.93M |
Operating Cash Flow | -3.11M | -2.49M | -3.04M | -2.1M | -3.26M | -2.15M | -2.12M | -1.49M | -4.89M | -4.04M | -4.41M | -2.45M | -4.69M | -4.88M | n/a | -3.94K | -8.57M | -5.05M | -5M | -1.56M | -4.87M | -7.42M |
Capital Expenditures | n/a | n/a | n/a | -3.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 382K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -15K | n/a | n/a | n/a | n/a | n/a | 382K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | -203K | -134.77K | -122K | 1.91M | -214K | -514K | -973K | -336K | 669K | -215K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 89 | n/a | -1.65K | -727K | 1.09M | -1K | 26K | n/a | 3K | 3K | 1K | 1K | n/a | n/a | 6.46K | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 8.04M | 53K | 5.76M | 1.88M | 3.38M | 2.13M | 2.15M | -443K | 7.76M | 1.51M | 3.52M | n/a | 291K | 3.21M | n/a | 6.46K | n/a | 12.37M | 1.12M | 11.18M | 1.99M | n/a |
Net Cash Flow | 4.93M | -2.44M | 2.72M | -227K | 129K | -17K | 413K | -1.93M | 2.87M | -2.54M | -886K | -2.45M | -4.4M | -1.67M | n/a | 8.13M | -8.57M | 7.36M | -4.03M | 9.6M | -2.88M | -7.39M |
Free Cash Flow | -3.11M | -2.49M | -3.04M | -2.1M | -3.26M | -2.15M | -2.12M | -1.49M | -4.89M | -4.04M | -4.41M | -2.45M | -4.69M | -4.88M | n/a | -3.94K | -8.57M | -5.05M | -5M | -1.56M | -4.87M | -7.42M |
Adj. Free Cash Flow | -3.82M | -2.79M | -4.23M | -2.1M | -3.98M | -3.17M | -3.38M | -1.74M | -4.89M | -4.34M | -4.71M | -2.75M | -4.97M | -5.15M | n/a | -4.2K | -8.7M | -5.15M | -5.08M | -1.63M | -4.95M | -7.5M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | -3.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -3.11M | -2.49M | -3.04M | -2.1M | -3.26M | -2.15M | -2.12M | -1.49M | -4.89M | -4.04M | -4.41M | -2.45M | -4.69M | -4.88M | n/a | -3.94K | -8.57M | -5.05M | -5M | -1.56M | -4.87M | -7.42M |
Add to Watchlist
Select watchlists to add or remove AKTX